Quantitative proteomic analysis of a paired human liverhealthy versus carcinoma cell lines with the same genetic background to identify potential hepatocellular carcinoma markers

Proteomics - Clinical Applications

Volumn 3, Issue 6, 2009, Pages 705-719

  Bao, Huimin ^a   Song, Peiming ^b   Liu, Qingping ^a   Liu, Yinkun ^a   Yun, Dong ^a   Saiyin, Hexige ^c   Du, Ruyun ^a   Zhang, Yang ^a   Fan, Huizhi ^a   Yang, Pengyuan ^a   Chen, Xian ^a,d  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Amino acid coded mass tagging; Biomarkers; Hepatocellular carcinoma; LC MS MS; Quantitative proteomics

Indexed keywords

ELONGATION FACTOR TU; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; HEAT SHOCK PROTEIN 27; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; LIPOCORTIN 5; NUCLEOLIN; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PROTEIN PRDX 4; PROTEIN PRDX 5; PROTEIN PRDX 6; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COMMUNICATION; CELL CYCLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; FUNCTIONAL PROTEOMICS; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; TANDEM MASS SPECTROMETRY; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING;

EID: 70350092344     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780128     Document Type: Article

References (65)

1. Tang, Z. Y., Ye, S. L., Liu, Y. K., Qin, L. X. et al., A decade's studies on metastasis of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2004, 130, 187-196.
2. Liang, C., Leow, C. K., Neo, J. C. H., Tan, G. S. et al., Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2005, 5, 2258-2271.
3. Luk, J. M., Lam, C. T., Siu, A. F. M., Lam, B. Y. et al., Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
4. Feng, J. T., Liu, Y. K., Song, H. Y., Dai, Z. et al., Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005, 5, 4581-4588.
5. Zhu, D.,Wang, J., The culture of the liver cell line QSG-7701, from a hepatoma donor, and its comparison with other hepatoma cell lines. Cancer Res. Prev. Treat. 1979, 6, 7-9.
6. Wang, J., Zhu, D., Ye, X., Chen, R., Establishment and some characteristics of a hepatoma cell line (QGY-7703). Chin. J. Oncol. 1981, 3, 241-244.
7. Li, J. H., Werner, E., Hergenhahn, M., Poirey, R. et al., Expression profiling of human hepatoma cells reveals global repression of genes involved in cell proliferation, growth, and apoptosis upon infection with parvovirus H-1. J. Virol. 2005, 79, 2274-2286.
8. Huang, R. M., Xing, Z. G., Luan, Z. D., Wu, T. M. et al., A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. Cancer Res. 2003, 63, 3775-3782.
9. Zhu, H. N., Pan, S. Q., Gu, S., Bradbury, E. M., Chen, X., Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun. Mass Spectrom. 2002, 16, 2115-2123.
10. Pan, S. Q., Gu, S., Bradbury, E. M., Chen,X., Single peptide-based protein identification in human proteome through MALDI-TOF MS coupled with amino acids coded mass tagging. Anal. Chem. 2003, 75, 1316-1324.
11. Gu, S., Liu, Z., Pan, S., Jiang, Z. et al., Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. Mol. Cell. Proteomics 2004, 3, 998-1008.
12. Gu, S., Pan, S. Q., Bradbury, E. M., Chen, X., Use of deuterium-labeled lysine for efficient protein identification and peptide de novo sequencing. Anal. Chem. 2002, 74, 5774-5785.
13. Gu, S., Chen, J., Dobos, K. M., Bradbury, E. M. et al., Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol. Cell. Proteomics 2003, 2, 1284-1296.
14. Gu, S., Du, Y., Chen, J., Liu, Z. et al., Large-scale quantitative proteomic study of PUMA-induced apoptosis using two-dimensional liquid chromatography-mass spectrometry coupled with amino acid-coded mass tagging. J. Proteome Res. 2004, 3, 1191-1200.
15. Peng, J. M., Elias, J. E., Thoreen, C. C., Licklider, L. J., Gygi, S. P., Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: The yeast proteome. J. Proteome Res. 2003, 2, 43-50.
16. Chen, R., Brentnall, T. A., Pan, S., Cooke, K. et al., Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol. Cell. Proteomics 2007, 6, 1331-1342.
17. Spooncer, E., Brouard, N., Nilsson, S. K., Williams, B. et al., Developmental fate determination and marker discovery in hematopoietic stem cell biology using proteomic fingerprinting. Mol. Cell. Proteomics 2008, 7, 573-581.
18. Xue, Y. Y. D., Esmon, A., Zou, P., Zuo, S. et al., Proteomic dissection of agonist-specific TLR-mediated inflammatory responses on macrophages at subcellular resolution. J. Proteome Res. 2008, 7, 3180-3193.
19. Cerwenka, H., Aigner, R., Bacher, H., Werkgartner, G. et al., TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions. Anticancer Res. 1999, 19, 849-851.
20. Wechsel, H. W., Petri, E., Bichler, K. H., Feil, G. et al., Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M-2 (Tu M2-PK). Anticancer Res. 1999, 19, 2583-2590.
21. Heather, R., Christofk, M. G. V. H., Ning, Wu, Asara, J. M., Cantley, L. C., Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452, 181-186.
22. Luk, J. M., Lam, C. T., Siu, A. F., Lam, B. Y. et al., Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
23. Li, C., Hong, Y., Tan, Y. X., Zhou, H. et al., Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol. Cell. Proteomics 2004, 3, 399-409.
24. Khalil, A. A., James, P., Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci. 2007, 98, 201-213.
25. Cappello, F., Di Stefano, A., David, S., Rappa, F. et al., HSP60 and HSP10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 2006, 107, 2417-2424.
26. Lebret, T., Watson, R. W. G., Molinie, V., O'Neill, A. et al., Heat shock proteins HSP27, HSP60, HSP70, and HSP90. Cancer 2003, 98, 970-977.
27. Zeindl-Eberhart, E., Haraida, S., Liebmann, S., Jungblut, P. R. et al., Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 2004, 39, 540-549.
28. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 2006, 6, 3894-3900.
29. Zhou, G., Li, H. M., DeCamp, D., Chen, S. et al., 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 2002, 1, 117-124.
30. Masaki, T., Tokuda, M., Ohnishi, M., Watanabe, S. et al., Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma. Hepatology 1996, 24, 72-81.
31. Kuramitsu, Y., Harada, T., Takashima, M., Yokoyama, Y. et al., Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Electrophoresis 2006, 27, 1651-1658.
32. Alfonso, P., Nunez, A., Madoz-Gurpide, J., Lombardia, L. et al., Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005, 5, 2602-2611.
33. Singer, S., Ehemann, V., Brauckhoff, A., Keith, M. et al., Protumorigenic overexpression of Stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 2007, 46, 759-768.
34. Yuan, R. H., Jeng, Y. M., Chen, H. L., Lai, P. L. et al., Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma. J. Pathol. 2006, 209, 549-558.
35. Chen, Y. C., Lin, M. C., Yao, H., Wang, H. et al., Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007, 46, 200-208.
36. Schultz-Norton, J. R., McDonald, W. H., Yates, J. R., Nardulli, A. M., Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function. Mol. Endocrinol. 2006, 20, 1982-1995.
37. Dillon, S. C., Zhang, X., Trievel, R. C., Cheng, X. D., The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005, 6.
38. Kim, J. H., Paek, K. Y., Choi, K. B., Kim, T. D. et al., Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell. Biol. 2003, 23, 708-720.
39. Zech, V. F. E., Dlaska, M., Tzankov, A., Hilbe, W., Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect. Prev. 2006, 30, 395-402.
40. Wu, S. L., Sato, M., Endo, C., Sakurada, A. et al., hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003, 41, 179-186.
41. Mongelard, F., Bouvet, P., Nucleolin: a multiFACeTed protein. Trends Cell Biol. 2007, 17, 80-86.
42. Angelov, D., Bondarenko, V. A., Almagro, S., Menoni, H. et al., Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. EMBO J. 2006, 25, 1669-1679.
43. Srivastava, M., Pollard, H. B., Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 1999, 13, 1911-1922.
44. Wilson, J. B., Bell, J. L., Levine, A. J., Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 1996, 15, 3117-3126.
45. Qi, Y. J., Chiu, J. F., Wang, L. D., Kwong, D. L. W., He, Q. Y., Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005, 5, 2960-2971.
46. He, Q. Y., Chen, J., Kung, H. F., Yuen, A. P. W., Chiu, J. F., Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004, 4, 271-278.
47. Shen, J. J., Person, M. D., Zhu, J. J., Abbruzzese, J. L., Li, D. H., Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004, 64, 9018-9026.
48. Friedman, D. B., Hill, S., Keller, J. W., Merchant, N. B. et al., Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 793-811.
49. Bernard, K., Litman, E., Fitzpatrick, J. L., Shellman, Y. G. et al., Functional proteomic analysis of melanoma progression. Cancer Res. 2003, 63, 6716-6725.
50. Sharma, S., Tammela, J., Wang, X., Arnouk, H. et al., Characterization of a putative ovarian oncogene, elongation factor 1 alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clin. Cancer Res. 2007, 13, 5889-5896.
51. Kulkarni, G., Turbin, D. A., Amiri, A., Jeganathan, S. et al., Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer Res. Treat. 2007, 102, 31-41.
52. Sharma, S., Driscoll, D., Odusni, K., The oncogene elongation factor 1 alpha-2 mRNA expression in epithelial ovarian cancer. J. Clin. Oncol. 2005, 23, 463S-463S.
53. Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S. et al., Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J. Proteome Res. 2005, 4, 2062-2069.
54. Park, K. S., Kim, H., Kim, N. G., Cho, S. Y. et al., Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 2002, 35, 1459-1466.
55. Kim, J., Kim, S. H., Lee, S. U., Ha, G. H. et al., Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 2002, 23, 4142-4156.
56. Sun, W., Xing, B. C., Sun, Y., Du, X. J. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis. Mol. Cell. Proteomics 2007, 6, 1798-1808.
57. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determinedby proteomic analysis. Proteomics 2005, 5, 1686-1692.
58. Blanc, J. F., Lalanne, C., Plomion, C., Schmitter, J. M. et al., Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005, 5, 3778-3789.
59. Li, C., Tan, Y. X., Zhou, H., Ding, S. J. et al., Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: identification of potential tumor markers. Proteomics 2005, 5, 1125-1139.
60. Ding, S.-J., Li, Y., Tan, Y.-X., Jiang, M.-R. et al., From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 2004, 3, 73-81.
61. Pike, S. E., Yao, L., Setsuda, J., Jones, K. D. et al., Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999, 94, 2461-2468.
62. Jungblut, P. R., Zimny-Arndt, U., Zeindl-Eberhart, E., Stulik, J. et al., Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis 1999, 20, 2100-2110.
63. Yokoyama, Y., Kuramitsu, Y., Takashima, M., Lizuka, N. et al., Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004, 4, 2111-2116.
64. Fujii, K., Kondo, T., Yokoo, H., Yamada, T. et al., Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 2005, 5, 1411-1422.
65. Cuezva, J. M., Krajewska, M., de Heredia, M. L., Krajewski, S. et al., The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 2002, 62, 6674-6681.